Epstein Secrets

as been proposed that negative symptoms represent a conse- quence of impaired frontal lobe function (Berge et al., 2011; Frith, 1992; Liddle, 1987; Weinberger, 1988). In fact, when Kraepelin (1919) introduced the concept of 'dementia praecox', he suggested that, based on the symptomatology of schizophren

eview. Journal of Neurology, Neurosurgery, and Psychiatry, 82, 476-486. ►Seeley, W.W, Bauer, A.M., Miller, B.L., Gorno-Tempini, M.L, Kramer, J.H., Weiner, M. & Rosen, H.J. (2005). The natural history of temporal variant frontotemporal dementia. Neural- ogy, 64, 1384-1390. ►Shaman, M.E., Dickey, C.C.,

onset schizophrenia]. Psychiatrische Praxis, 30, 878-82. ►Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., ... Traynor, B.). (2011). A hexanu- cleotide repeat expansion in C9ORF72 is the cause of chromo- some 9p21-linked ALS-ETD. Neuron, 72, 257-268. Reynolds, J. (18

ssee. for appellants. Hunton & Williams LLP, and Marty Steinberg and Jeffrey W. Gutchess; Ross & Girten

... so long as the act has some relation to the proceeding." Echevarria, 950 So.2d at 384 (quoting Levin, 639 So.2d at 608), see also DelMonico v. Traynor, — So.3d 38 Fla. L. Weekly S106, 2013 WL 535451 (Fla.2013) (clarifying that, although not all statements made outside of the formal judicial pro

aim, particularly where Epstein fails to allege that he was required to do something as the result of Edwards’ pursuit of the claims against him, See Marty v. Gresh, 501 So.2d 87, 90 (Fla, 1* Dist. Ct. App. 1987) (affirming summary judgment on an abuse of process claim where “appellant’s lawsuit caused

s in preparation for and connected to pending litigation are covered by the absolute immunity conferred by the litigation privilege. See DelMonico v. Traynor, 50 So. 3d 4 (Fla. Dist. Ct. App. 4th Dist. 2010), review granted, 47 So. 3d 1287 (Fla. 2010). The privilege extends to statements in judicial procee